Search Results - "PELLEGRINI, Fabio"

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review by Franciosi, Monica, Lucisano, Giuseppe, Lapice, Emanuela, Strippoli, Giovanni F M, Pellegrini, Fabio, Nicolucci, Antonio

“…Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin…”
Get full text

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study by Kappos, Ludwig, Butzkueven, Helmut, Wiendl, Heinz, Spelman, Timothy, Pellegrini, Fabio, Chen, Yi, Dong, Qunming, Koendgen, Harold, Belachew, Shibeshih, Trojano, Maria

“…Background: Confirmed Expanded Disability Status Scale (EDSS) progression occurring after a fixed-study entry baseline is a common measure of disability…”
Get full text

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review by Karim, Mohammad Ehsanul, Pellegrini, Fabio, Platt, Robert W, Simoneau, Gabrielle, Rouette, Julie, de Moor, Carl

“…Background: Propensity score (PS) analyses are increasingly used in multiple sclerosis (MS) research, largely owing to the greater availability of large…”
Get full text

Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network by Iaffaldano, Pietro, Lucisano, Giuseppe, Butzkueven, Helmut, Hillert, Jan, Hyde, Robert, Koch-Henriksen, Nils, Magyari, Melinda, Pellegrini, Fabio, Spelman, Tim, Sørensen, Per Soelberg, Vukusic, Sandra, Trojano, Maria

“…Background: The optimal timing of treatment starts for achieving the best control on the long-term disability accumulation in multiple sclerosis (MS) is still…”
Get full text

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis by Pellegrini, Fabio, Copetti, Massimiliano, Bovis, Francesca, Cheng, David, Hyde, Robert, de Moor, Carl, Kieseier, Bernd C, Sormani, Maria Pia

“…Background: Stratified medicine methodologies based on subgroup analyses are often insufficiently powered. More powerful personalized medicine approaches are…”
Get full text

Recommendations for the use of propensity score methods in multiple sclerosis research by Simoneau, Gabrielle, Pellegrini, Fabio, Debray, Thomas PA, Rouette, Julie, Muñoz, Johanna, Platt, Robert W., Petkau, John, Bohn, Justin, Shen, Changyu, de Moor, Carl, Karim, Mohammad Ehsanul

“…Background: With many disease-modifying therapies currently approved for the management of multiple sclerosis, there is a growing need to evaluate the…”
Get full text

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials by Palmer, Suetonia C, Nistor, Ionut, Craig, Jonathan C, Pellegrini, Fabio, Messa, Piergiorgio, Tonelli, Marcello, Covic, Adrian, Strippoli, Giovanni F M

“…Calcimimetic agents lower serum parathyroid hormone levels in people with chronic kidney disease (CKD), but treatment effects on patient-relevant outcomes are…”
Get full text

Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies by Palmer, Suetonia C., MBChB, PhD, Vecchio, Mariacristina, MSc, Craig, Jonathan C., MBChB, PhD, Tonelli, Marcello, MD, Johnson, David W., MBBS (Hons), PhD, Nicolucci, Antonio, MD, Pellegrini, Fabio, MSc, Saglimbene, Valeria, MSc, Logroscino, Giancarlo, PhD, Hedayati, S. Susan, MD, Strippoli, Giovanni F.M., MD, MM, MPH, PhD

“…Background Depression occurs relatively commonly in people with chronic kidney disease (CKD), but it is uncertain whether depression is a risk factor for…”
Get full text

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis by Fontana, Andrea, Spadaro, Sara, Copetti, Massimiliano, Spoto, Belinda, Salvemini, Lucia, Pizzini, Patrizia, Frittitta, Lucia, Mallamaci, Francesca, Pellegrini, Fabio, Trischitta, Vincenzo, Menzaghi, Claudia

“…Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. To investigate the association…”
Get full text

Mirna expression profiles identify drivers in colorectal and pancreatic cancers by Piepoli, Ada, Tavano, Francesca, Copetti, Massimiliano, Mazza, Tommaso, Palumbo, Orazio, Panza, Anna, di Mola, Francesco Fabio, Pazienza, Valerio, Mazzoccoli, Gianluigi, Biscaglia, Giuseppe, Gentile, Annamaria, Mastrodonato, Nicola, Carella, Massimo, Pellegrini, Fabio, di Sebastiano, Pierluigi, Andriulli, Angelo

“…Altered expression of microRNAs (miRNAs) hallmarks many cancer types. The study of the associations of miRNA expression profile and cancer phenotype could help…”
Get full text

Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling by Pellegrini, Fabio, Copetti, Massimiliano, Sormani, Maria Pia, Bovis, Francesca, de Moor, Carl, Debray, Thomas PA, Kieseier, Bernd C

“…Background: There is an unmet need for precise methods estimating disease prognosis in multiple sclerosis (MS). Objective: Using advanced statistical modeling,…”
Get full text

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) by Mowry, Ellen M, Bermel, Robert A, Williams, James R, Benzinger, Tammie L S, de Moor, Carl, Fisher, Elizabeth, Hersh, Carrie M, Hyland, Megan H, Izbudak, Izlem, Jones, Stephen E, Kieseier, Bernd C, Kitzler, Hagen H, Krupp, Lauren, Lui, Yvonne W, Montalban, Xavier, Naismith, Robert T, Nicholas, Jacqueline A, Pellegrini, Fabio, Rovira, Alex, Schulze, Maximilian, Tackenberg, Björn, Tintore, Mar, Tivarus, Madalina E, Ziemssen, Tjalf, Rudick, Richard A

“…Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS)…”
Get full text

Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients by Fontana, Luigi, Addante, Filomena, Copetti, Massimiliano, Paroni, Giulia, Fontana, Andrea, Sancarlo, Daniele, Pellegrini, Fabio, Ferrucci, Luigi, Pilotto, Alberto

“…Summary A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple…”
Get full text

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis by Debray, Thomas PA, Simoneau, Gabrielle, Copetti, Massimiliano, Platt, Robert W, Shen, Changyu, Pellegrini, Fabio, de Moor, Carl

“…Real-world data sources offer opportunities to compare the effectiveness of treatments in practical clinical settings. However, relevant outcomes are often…”
Get full text

CARMELA: Assessment of Cardiovascular Risk in Seven Latin American Cities by Schargrodsky, Herman, MD, Hernández-Hernández, Rafael, MD, Champagne, Beatriz Marcet, PhD, Silva, Honorio, MD, Vinueza, Raúl, MD, Silva Ayçaguer, Luis Carlos, PhD, Touboul, Pierre-Jean, MD, Boissonnet, Carlos Pablo, MD, Escobedo, Jorge, MD, Pellegrini, Fabio, MSc, Macchia, Alejandro, MD, Wilson, Elinor, PhD

“…Abstract Objective This cross-sectional, population-based observational study using stratified multistage sampling assessed the prevalence of cardiovascular…”
Get full text

The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy by Ingrasciotta, Ylenia, Sultana, Janet, Giorgianni, Francesco, Caputi, Achille Patrizio, Arcoraci, Vincenzo, Tari, Daniele Ugo, Linguiti, Claudio, Perrotta, Margherita, Nucita, Andrea, Pellegrini, Fabio, Fontana, Andrea, Cavagna, Lorenzo, Santoro, Domenico, Trifirò, Gianluca

“…The use of nephrotoxic drugs can further worsening renal function in chronic kidney disease (CKD) patients. It is therefore imperative to explore prescribing…”
Get full text

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes by Menzaghi, Claudia, Bacci, Simonetta, Salvemini, Lucia, Mendonca, Christine, Palladino, Giuseppe, Fontana, Andrea, De Bonis, Concetta, Marucci, Antonella, Goheen, Elizabeth, Prudente, Sabrina, Morini, Eleonora, Rizza, Stefano, Kanagaki, Alyssa, Fini, Grazia, Mangiacotti, Davide, Federici, Massimo, De Cosmo, Salvatore, Pellegrini, Fabio, Doria, Alessandro, Trischitta, Vincenzo

“…High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited…”
Get full text

Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial by Costantini, Massimo, Dr, Romoli, Vittoria, MS, Leo, Silvia Di, PSyD, Beccaro, Monica, MA, Bono, Laura, MA, Pilastri, Paola, RN, Miccinesi, Guido, MD, Valenti, Danila, MD, Peruselli, Carlo, MD, Bulli, Francesco, PSyD, Franceschini, Catia, RN, Grubich, Sergio, RN, Brunelli, Cinzia, MSc, Martini, Cinzia, MD, Pellegrini, Fabio, MS, Higginson, Irene J, Prof

“…Summary Background The quality of care provided to patients with cancer who are dying in hospital and their families is suboptimum. The UK Liverpool Care…”
Get full text

Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis by Palmer, Suetonia C., MBChB, PhD, Di Micco, Lucia, MD, Razavian, Mona, MBBS, Craig, Jonathan C., MBChB, DCH, MM, PhD, Ravani, Pietro, MD, PhD, Perkovic, Vlado, MBBS, PhD, Tognoni, Gianni, MD, Graziano, Giusi, MSc, Jardine, Meg, MBBS, PhD, Pellegrini, Fabio, MSc, Nicolucci, Antonio, MD, Webster, Angela, MBBS, PhD, Strippoli, Giovanni F.M., MD, PhD, MPH, MM

“…Background Hemodialysis vascular access failure occurs often and increases morbidity for people on hemodialysis therapy. Antiplatelet agents may prevent…”
Get full text

Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study by Palmer, Suetonia C., PhD, Ruospo, Marinella, MSc, Wong, Germaine, PhD, Craig, Jonathan C., PhD, Petruzzi, Massimo, PhD, De Benedittis, Michele, PhD, Ford, Pauline, PhD, Johnson, David W., PhD, Tonelli, Marcello, MD, Natale, Patrizia, MSc, Saglimbene, Valeria, MSc, Pellegrini, Fabio, MSc, Celia, Eduardo, MD, Gelfman, Ruben, MD, Leal, Miguel R., MD, Torok, Marietta, MD, Stroumza, Paul, MD, Bednarek-Skublewska, Anna, MD, Dulawa, Jan, MD, Frantzen, Luc, MD, Ferrari, Juan Nin, MD, del Castillo, Domingo, MD, Bernat, Amparo G., MD, Hegbrant, Jorgen, PhD, Wollheim, Charlotta, MSc, Gargano, Letizia, MSc, Bots, Casper P., PhD, Strippoli, Giovanni F.M., MD, PhD

“…Background Dental disease is more extensive in adults with chronic kidney disease, but whether dental health and behaviors are associated with survival in the…”
Get full text